Cronos Group (TSE:CRON) Shares Down 1.4% - Should You Sell?

Key Points

• Cronos Group Inc. shares fell 1.4% to C$3.43, with trading volume down 47% from its average.
• The company has a market capitalization of C$1.31 billion and maintains a high price-to-earnings ratio of 68.60.
• Cronos operates primarily in Canada but also exports medicinal cannabis to Poland and Germany, with joint ventures in several other countries.

Shares of Cronos Group Inc. (TSE:CRON - ) fell 1.4% during trading on Monday . The stock traded as low as C$3.41 and last traded at C$3.43. 101,000 shares changed hands during mid-day trading, a decline of 47% from the average session volume of 188,844 shares. The stock had previously closed at C$3.48.

Cronos Group Stock Down 1.4%

The firm's 50-day moving average price is C$3.11 and its 200 day moving average price is C$2.80. The firm has a market capitalization of C$1.31 billion, a price-to-earnings ratio of 68.60, a price-to-earnings-growth ratio of 0.12 and a beta of 1.21. The company has a debt-to-equity ratio of 0.17, a current ratio of 24.24 and a quick ratio of 24.01.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.